Role of abnormal vaginal microbiota in the pathogenesis of recurrent lower urinary tract infection: a modern view of the problem


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review is devoted to the problem of recurrent urinary tract infections (RUTIs) in women. It considers risk factors for RUTIs and the role of abnormal vaginal microbiota in this disease. E. coli have special virulence factors that cause urinary tract infection and colonization by adhesion to urothelial cells: the pronounced virulence of Type 1 factor (or Type 1 pili), which triggers an inflammatory response by attracting neutrophils to the bladder. Despite the fact that RUTIs are not considered a life threatening disease, they have a significant impact on quality of life, disabling effects on women's health, intimate and social relationships, self-rating and work ability, and also lead to irritability, fatigue, and inability to concentrate until depression develops. There are modern views on bacterial vaginosis and the associated new pathogenesis of RUTIs. The existing relationship between the factors of RUTIs, sexual practice, and the composition of the vaginal microbiome requires correction of the composition of the vaginal flora and the implementation of preventive measures and non-antimicrobial treatment. The major mechanisms of RUTI development are reinfection and bacterial persistence. Female RUTIs are associated with a steady upward entrance of the microflora from the periurethral region. Antibiotics are the most common treatment regimen for urinary tract infections (UTIs), at the same time they are becoming increasingly ineffective due to the emergence of antibiotic-resistant microorganisms. The global emergence of multidrug-resistant UPEC strains over the past decade highlights the need for alternative therapeutic and preventive strategies to combat UTIs. Conclusion. Thus, a vicious circle is formed: the patient takes antibiotics often or even continuously for the treatment of cystitis, which leads to the development of vaginal dysbiosis, bacterial vaginosis, candidiasis, and vulvar and urethral discomfort. The presented results of clinical trials have confirmed the rationale, efficiency, and safety of taking vitamin D, D-mannose, and proanthocyanidins in the treatment, prevention, and rehabilitation of patients with UTIs.

Full Text

Restricted Access

About the authors

A. V Zaitsev

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia

Email: zaitcevandrew@mail.ru
Dr. Med. Sci., Professor at the Department of Urology 127473, Russia, Moscow, Delegatskaya str., 20/1

I. A Apolikhina

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

MD, PhD, professor, Head of the Department of Aesthetic gynecology and Rehabilitation, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; Professor of the Department of Obstetrics, Gynecology, Perinatology and Reproductology, Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia; President of Association of Aesthetic Gynecology Specialists (AAGS), President of European Association for Genital Aesthetic Medicine and Plastic Surgery (EAGAMPS) 117997, Russia, Moscow, Akademika Oparina str., 4

L. A Khodyreva

Research Institute for the Organization of Healthcare and Medical Management, Moscow Department of Healthcare

Email: khodyreva60@mail.ru
Ph.D, Head of the Department of organizational and methodical support for the urology 115088, Russia, Moscow, Sharikopodshipnikovskaya str., 9

A. N Bernikov

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia

Email: bernikov@mac.com
PhD, Associate professor at the Department of Urology 127473, Russia, Moscow, Delegatskaya str., 20/1

Yu. A Kupriyanov

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia

Email: dr.kupriyanov@mail.ru
PhD, MD, assistant at the Department of Urology 127473, Russia, Moscow, Delegatskaya str., 20/1

R. V Stroganov

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia

PhD, assistant at the Department of Urology 127473, Russia, Moscow, Delegatskaya str., 20/1

O. A Arefyeva

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia

PhD, assistant at the Department of Urology 127473, Russia, Moscow, Delegatskaya str., 20/1

T. A Teterina

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: t_teterina@oparina4.ru
D, PhD, gynecologist of the Department of Aesthetic Gynecology and Rehabilitation 117997, Russia, Moscow, Akademika Oparina str., 4

References

  1. Aydin A, Ahmed K., Zaman I., Khan M.S., Dasgupta P. Recurrent urinary tract infections in women. Int. Urogynecol. J. 2015; 26(6): 795-804. https:// dx.doi.org/10.1007/s00192-014-2569-5.
  2. Foxman B. Urinary tract infection syndromes: occurrence,recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North Am. 2014; 28(1): 1-13. https://dx.doi.org/10.1016/j.idc.2013.09.003.
  3. Nosseir S.B., Lind L.R., Winkler H.A. Recurrent uncomplicated urinary tract infections in women: a review. J. Womens Health (Larchmt). 2012; 21(3): 347-54. https://dx.doi.org/10.1089/jwh.2011.3056.
  4. Lakeman M.M., Roovers J.P. Urinary tract infections in women with urogynaecological symptoms. Curr. Opin. Infect. Dis. 2016: 29(1): 92-7. https:// dx.doi.org/10.1097/QCO.0000000000000229.
  5. Flower A., Bishop F.L., Lewith G. How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum. BMC Fam. Pract. 2014; 15: 162. https://dx.doi.org/10.1186/1471-2296-15-162.
  6. Leydon G.M., Turner S, Smith H., Little P. Women’s views about management and cause of urinary tract infection: qualitative interview study. Br. Med. J. 2010; 340: c279. https://dx.doi.org/10.1136/bmj.c279.
  7. Graziottin A., Murina F, Gambini D., Taraborrelli S., Gardella B., Campo M.; VuNet Study Group. Vulvar pain: The revealing scenario of leading comorbidities in 1183 cases. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 252: 50-5. https:// dx.doi.org/10.1016/j.ejogrb.2020.05.052.
  8. Hooton T.M., Stamm W.E. Diagnosis and treatment of uncomplicated urinary tract infection. Infect. Dis. Clin. North Am. 1997; 11(3): 551-81. https:// dx.doi.org/10.1016/s0891-5520(05)70373-1.
  9. European Association of Urology. Guidelines on urological infections. 2021.
  10. Hooton T.M., Stapleton A.E., Roberts P.L., Winter C., Scholes D., Bavendam T., Stamm W.E. Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin. Infect. Dis. 1999; 29(6): 1600-1. https://dx.doi.org/10.1086/313528.
  11. Гвоздев М.Ю., Лоран О.Б., Гумин Л.М., Дьяков В.В. Транспозиция дистального отдела уретры в оперативном лечении рецидивирующей инфекции нижних мочевыводящих путей у женщин. Урология. 2000; 3: 24-7.
  12. Gyftopoulos K. The aberrant urethral meatus as a possible aetiological factor of recurrent post-coital urinary infections in young women. Med. Hypotheses. 2018; 113: 6-8. https://dx.doi.org/10.1016/j.mehy.2018.02.005.
  13. Stapleton A.E. The vaginal microbiota and urinary tract infection. Microbiol. Spectr. 2016; 4(6): 10.1128/microbiolspec.UTI-0025-2016. https:// dx.doi.org/10.1128/microbiolspec.UTI-0025-2016.
  14. Pfau A., Sacks T. The bacterial flora of the vaginal vestibule, urethra and vagina in premenopausal women with recurrent urinary tract infections. J. Urol. 1981; 126(5): 630-4. https://dx.doi.org/10.1016/s0022-5347(17)54661-3.
  15. Tachedjian G., Aldunate M., Bradshaw C.S., Cone R.A. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res. Microbiol. 2017; 168(9-10): 782-92. https://dx.doi.org/10.1016/j.resmic.2017.04.001.
  16. Navas-Nacher E.L., Dardick F., Venegas M.F., Anderson B.E., Schaeffer A.J., Duncan J.L. Relatedness of Escherichia coli colonizing women longitudinally. Mol. Urol. 2001; 5(1): 31-6. https://dx.doi.org/10.1089/109153601750124285.
  17. Ravel J., Gaj'er P., Abdo Z., Schneider G.M., Koenig S.S.K., McCulle S.L. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA. 2011; 108; (Suppl. 1): 4680-7. https://dx.doi.ois/10.1073/pnas.1002611107.
  18. Соловьева А.В., Гаче В. Нарушения биоценоза влагалища у женщин репродуктивного возраста. Акушерство и инекология. 2017; 4: 126-31.
  19. Van de Wijgert J.H.H.M. The vaginal microbiome and sexually transmitted infections are interlinked: Consequences for treatment and prevention. PLoS Med. 2017; 14(12): e1002478. https://dx.doi.org/10.1371/ journal.pmed.1002478.
  20. Harmanli O.H., Cheng G.Y., Nyirjesy P., Chatwani A., Gaughan J.P. Urinary tract infections in women with bacterial vaginosis. Obsteto Gynecol. 2000; 95(5): 710-2. https://dx.doi.org/10.1016/s0029-7844(99)00632-8.
  21. Hillebrand L., Harmanli O.H., Whiteman V., Khandelwal M. Urinary tract infections in pregnant women with bacterial vaginosis. Am. J. Obstet. Gynecol. 2002; 186(5): 916-7. https://dx.doi.org/10.1067/mob.2002.123987.
  22. Ильина И.Ю., Доброхотова Ю.Э. Бактериальный вагиноз. Возможные пути решения проблемы. РМЖ. 2020; 11: 75-8.
  23. Аполихина И.А., Эфендиева З.Н. Современные направления в лечении бактериального вагиноза. Акушерство и гинекология. 2019; 12: 193-6
  24. Jung H., Peters R.P.H., Lombaard H., Ehlers M.M. Growth forms of Gardnerella spp. and Lactobacillus spp. on vaginal cells. Front. Cell. Infect. Microbiol. 2020; 10: 71. https://dx.doi.org/10.3389/fcimb.2020.00071.
  25. Muzny C.A., Taylor C.M., Swords W.E., Tamhane A., Chattopadhyay D., Cerca N., Schwebke J.R. An updated conceptual model on the pathogenesis of bacterial vaginosis. J. Infect. Dis. 2019; 220(9): 1399-405. https://dx.doi.org/10.1093/ infdis/jiz342.
  26. Vaneechoutte M., Guschin A., Van Simaey L., Gansemans Y., Van Nieuwerburgh F., Cools P. Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella. Int. J. Syst. Evol. Microbiol. 2019; 69(3): 679-87. https:// dx.doi.org/10.1099/ijsem.0.003200.
  27. O'Brien V.P., Hannan T.J., Nielsen H.V., Hultgren S.J. Drug and vaccine development for the treatment and prevention of urinary tract infections. Microbiol. Spectr. 2016; 4(1): 10.1128/microbiolspec.UTI-0013-2012. https:// dx.doi.org/10.1128/microbiolspec.UTI-0013-2012.
  28. Lewis A.L., Gilbert N.M. Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models. GMS Infect. Dis. 2020; 8: Doc02. https://dx.doi.org/10.3205/id000046.
  29. Ratten L.K., Plummer E.L., Murray G.L., Danielewski J., Fairley C.K., Garland S.M. et al. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study. BJOG. 2021; 128(4): 756-67. https://dx.doi.org/10.1111/ 1471-0528.16430.
  30. Reed J.F. Jr. Urethral-hymenal fusion: a cause of chronic adult female cystitis. J. Urol. 1970; 103(4): 441-6. https://dx.doi.org/10.1016/s0022-5347(17)61977-3.
  31. Гвоздев М.Ю. Транспозиция уретры: особенности и отдаленные результаты. Дайджест урологии. 2018; 2: 18-24
  32. Bergamin P.A., Kiosoglous A.J. Non-surgical management of recurrent UTIs. Transl. Androl. Urol. 2017; 6(Suppl. 2): S142-52. https://dx.doi.org/10.21037/ tau.2017.06.09.
  33. Morrill S., Gilbert N.M., Lewis A.L. Gardnerella vaginalis as a cause of bacterial vaginosis: appraisal of the evidence from in vivo models. Front. Cell. Infect. Microbiol. 2020; 10: 168. https://dx.doi.org/10.3389/fcimb.2020.00168.
  34. Кульчавеня Е.В., Бреусов А.А. Рецидивирующий цистит и бактериальный вагиноз: как избежать полипрагмазии. Гинекология. 2020; 22(4): 17-21.
  35. Schaeffer A.J., Amundsen S.K., Jones J.M. Effect of carbo-hydrates on adherence of Escherichia coli to human urinary tract epithelial cells. Infec.t Immun. 1980; 30: 531-7.
  36. Schaeffer A.J., Chmiel J.S., Duncan J.L., Falkowski W.S. Mannose-sensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J. Urol. 1984; 131(5): 906-10. https:// dx.doi.org/10.1016/s0022-5347(17)50706-5.
  37. Kranjcec B, Papes D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J. Urol. 2014; 32: 79-84. https://dx.doi.org/10.1007/s00345-013-1091-6.
  38. Domenici L, Monti M, Bracchi C., Giorgini M., Colagiovanni V., Muzii L., Panici P.B. D-Mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur. Rev. Med. Pharmacol. Sci. 2016; 20(13): 2920-5.
  39. Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А. Эффективность комбинированной антибактериально-пребиотической терапии в сочетании с D-маннозой у женщин с неосложненной инфекцией нижних мочевых путей. Урология. 2019; 6: 38-43.
  40. Franssen M., Cook J., Robinson J., Williams N., Glogowska M., Yang Y. et al. D-Mannos E to prevent recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial. BMJ Open. 2021; 11(1): e037128. https:// dx.doi.org/10.1136/bmjopen-2020-037128.
  41. Sobota A.E. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J. Urol. 1984; 131(5): 1013-6. https:// dx.doi.org/10.1016/S0022-5347 (17) 50751-X.
  42. Jepson R.G., Mihaljevic L., Graig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst. Rev. 2004; (1): CD001321. https:// dx.doi.org/10.1002/14651858.CD001321.
  43. Lenger S.M., Bradley M.S., Thomas D.A., Bertolet M.H., Lowder J.L., Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2020; 223(2): 265. e1-265. e13. https://dx.doi.org/10.1016/j.ajog.2020.05.048.
  44. Hertting O., Holm A., Luthje P., Brauner H., Dyrdak R., Jonasson A.F. et al. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One. 2010; 5: e15580. https://dx.doi.org/10.1371/ journal.pone.0015580.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies